VBI Vaccines Inc logo

VBIV - VBI Vaccines Inc Share Price

$3.58 -0.2  -4.8%

Last Trade - 9:00pm

Mid Cap
Market Cap £670.1m
Enterprise Value £615.7m
Revenue £1.40m
Position in Universe 2487th / 6371
Unlock VBIV Revenue
Relative Strength (%)
1m -8.58%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -45.7%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.96 0.55 0.87 3.36 2.22 1.31 6.73
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 June 2020, VBI Vaccines Inc revenues decreased 40% to $599K. Net loss decreased 36% to $17.9M. Revenues reflect R&D Service revenue segment decrease of 38% to $166K, Product revenue segment decrease of 81% to $18K, China/Hong Kong segment decrease of 49% to $396K, Europe segment decrease of 25% to $52K. Lower net loss reflects Foreign exchange (loss)/gain increase from $642K (expense) to $948K (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for VBIV
Graphical History


VBIV Revenue Unlock VBIV Revenue

Net Income

VBIV Net Income Unlock VBIV Revenue

Normalised EPS

VBIV Normalised EPS Unlock VBIV Revenue

PE Ratio Range

VBIV PE Ratio Range Unlock VBIV Revenue

Dividend Yield Range

VBIV Dividend Yield Range Unlock VBIV Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
VBIV EPS Forecasts Unlock VBIV Revenue
Profile Summary

VBI Vaccines Inc. is a development-stage biotechnology company. The Company's principal products include cytomegalovirus (CMV) Vaccine Candidate, enveloped Virus Like Particle (eVLP) Vaccine Platform and Lipid Particle Vaccine (LPV) Vaccine Platform. The Company is also engaged in the research and development (R and D) activity. The Company's subsidiaries includes Variation Biotechnologies (US), Inc. (VBI US) and Variation Biotechnologies Inc. (VBI Cda).

Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated April 9, 1965
Public Since January 13, 2010
No. of Shareholders: 814
No. of Employees: 123
Sector Healthcare
Industry Biotechnology & Medical Research
Index Nasdaq Composite ,
Exchange NASDAQ Capital Market
Shares in Issue 231,198,396
Free Float (0.0%)
Eligible for
VBIV Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for VBIV
Upcoming Events for VBIV
Frequently Asked Questions for VBI Vaccines Inc
What is the VBI Vaccines Inc share price?

As of 9:00pm, shares in VBI Vaccines Inc are trading at $3.58, giving the company a market capitalisation of £670.1m. This share price information is delayed by 15 minutes.

How has the VBI Vaccines Inc share price performed this year?

Shares in VBI Vaccines Inc are currently trading at $3.58 and the price has moved by 0.459k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the VBI Vaccines Inc price has moved by 0.396k% over the past year.

What are the analyst and broker recommendations for VBI Vaccines Inc?

Of the analysts with advisory recommendations for VBI Vaccines Inc, there are there are currently 3 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for VBI Vaccines Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will VBI Vaccines Inc next release its financial results?

VBI Vaccines Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the VBI Vaccines Inc dividend yield?

VBI Vaccines Inc does not currently pay a dividend.

Does VBI Vaccines Inc pay a dividend?

VBI Vaccines Inc does not currently pay a dividend.

When does VBI Vaccines Inc next pay dividends?

VBI Vaccines Inc does not currently pay a dividend.

How do I buy VBI Vaccines Inc shares?

To buy shares in VBI Vaccines Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of VBI Vaccines Inc?

Shares in VBI Vaccines Inc are currently trading at $3.58, giving the company a market capitalisation of £670.1m.

Where are VBI Vaccines Inc shares listed? Where are VBI Vaccines Inc shares listed?

Here are the trading details for VBI Vaccines Inc:

Country of listing: United States
Exchange: NAQ
Ticker Symbol: VBIV
What kind of share is VBI Vaccines Inc?

Based on an overall assessment of its quality, value and momentum, VBI Vaccines Inc is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a VBI Vaccines Inc share price forecast 2020?

Shares in VBI Vaccines Inc are currently priced at $3.58. At that level they are trading at 36.37% discount to the analyst consensus target price of 0.00.

Analysts covering VBI Vaccines Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.1833614403 for the next financial year.

How can I tell whether the VBI Vaccines Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like VBI Vaccines Inc. Over the past six months, the relative strength of its shares against the market has been 0.217k%. At the current price of $3.58, shares in VBI Vaccines Inc are trading at 72.05% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the VBI Vaccines Inc PE Ratio?

We were not able to find PE ratio data for VBI Vaccines Inc.

Who are the key directors of VBI Vaccines Inc?

VBI Vaccines Inc's management team is headed by:

Christopher McNulty - CFO
Joanne Cordeiro - IND
Jeffrey Baxter - PRE
Steven Gillis - CHM
Michel Wilde - IND
David Anderson - CSO
Francisco Diaz-Mitoma - OTH
Nell Beattie - OTH
Avi Mazaltov - GMG
Blaine Mckee - IND
Damian Braga - IND
Who are the major shareholders of VBI Vaccines Inc?

Here are the top five shareholders of VBI Vaccines Inc based on the size of their shareholding:

Perceptive Advisors LLC Private Equity
Percentage owned: 23.81% (55.0m shares)
ARCH Venture Partners Venture Capital
Percentage owned: 5.63% (13.0m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 5.16% (11.9m shares)
OPKO Health Inc Corporation
Percentage owned: 2.89% (6.68m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 2.62% (6.06m shares)
Similar to VBIV
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.